TipRanks
Go Ultimate55% OFF

Amexdrug (AXRX) Financial Statements

Amexdrug Financial Overview

Amexdrug's market cap is currently $33.88K. The company's EPS TTM is ―; its P/E ratio is 0.50; Amexdrug has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 17
Income Statement
Total Revenue$ 10.43M
Gross Profit$ 1.96M
Operating Income$ 214.62K
EBITDA$ 226.81K
Net Income$ 111.36K
Balance Sheet
Cash & Short-Term Investments$ 245.03K
Total Assets$ 2.31M
Total Debt$ 799.66K
Net Debt$ 564.24K
Total Liabilities$ 1.51M
Stockholders' Equity$ 806.69K
Cash Flow
Free Cash Flow$ 27.49K
Operating Cash Flow$ 27.49K
Investing Cash Flow$ 0.00
Financing Cash Flow$ -10.63K

Currency in USD

Amexdrug Earnings and Revenue History

04M8M12M0 %1 %2 %3 %EarningsProfit Margin2017RevenueEarningsProfit Margin

Amexdrug Debt to Assets

01M2M3M64 %65 %66 %67 %LiabilitiesDebt to Assets2017AssetsLiabilitiesDebt to Assets

Amexdrug Cash Flow

-20K-10K010K20K30K2017OperatingInvestingFinancing

Amexdrug Forecast EPS vs Actual EPS